Skip to main content

Want a detailed portfolio tracker?

Kiora Pharmaceuticals (KPRX) P/E (2015 - 2026)

Kiora Pharmaceuticals (KPRX) P/E from Jul 31, 2015 to Jul 21, 2026. The TTM Kiora Pharmaceuticals (KPRX) P/E is -0.86. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Kiora Pharmaceuticals (KPRX)

YearP/EChange
2026-0.86+33.80%
2025-0.64-125.60%
20242.50-1770.63%
2023-0.15-87.08%
2022-1.16-94.32%
2021-20.39-54.12%
2020-44.44-37.59%
2019-71.21+237.70%
2018-21.09+40.30%
2017-15.03-12.52%
2016-17.18-49.52%
2015-34.03N/A

Comparison Kiora Pharmaceuticals (KPRX) P/E with competitors

Kiora Pharmaceuticals (KPRX) P/E is -0.86.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.20%
NBYStablecoin Development Corp0.00-100.50%
ENLVEnlivex Ltd0.07-108.74%
FGENFibroGen Inc0.24-128.05%
CHRSCoherus Biosciences Inc0.85-199.16%
FBIOFortress Biotech Inc0.95-210.90%
ORMPOramed Pharmaceuticals Inc1.50-275.65%
AGENAgenus Inc3.01-451.70%
INVAInnoviva Inc3.15-468.58%
VXRTVaxart Inc3.55-514.82%
CRMDCorMedix Inc3.63-524.02%
CVACCureVac N.V.4.45-619.52%
GLPGGalapagos NV4.86-667.81%
SRPTSarepta Therapeutics Inc4.88-670.52%
ABEOAbeona Therapeutics Inc5.39-729.59%
ABUSArbutus Biopharma Corp5.60-753.90%
ZVRAZevra Therapeutics Inc5.89-787.98%
SPROSpero Therapeutics Inc6.23-827.86%
CGENCompugen Ltd6.31-837.85%
RIGLRigel Pharmaceuticals6.87-903.07%
SLXNSilexion Therapeutics Corp7.30-952.62%
OMEROmeros Corporation9.26-1181.98%
AUPHAurinia Pharmaceuticals Inc9.58-1220.10%
PLXProtalix BioTherapeutics Inc10.89-1372.73%
ACADAcadia Pharmaceuticals Inc11.73-1470.60%
TBPHTheravance Biopharma Inc12.26-1532.96%
ADMAAdma Biologics Inc12.42-1551.19%
HRMYHarmony Biosciences Holdings Inc13.82-1715.04%
SABSSAB Biotherapeutics Inc14.14-1751.96%
NAGENiagen Bioscience Inc14.82-1831.65%
INCYIncyte Corp15.82-1949.03%
REGNRegeneron Pharmaceuticals Inc15.86-1953.02%
PBYIPuma Biotechnology Inc17.32-2123.52%
CPRXCatalyst Pharmaceuticals Inc17.44-2137.97%
EXELExelixis Inc17.54-2149.50%
TGTXTG Therapeutics Inc18.97-2316.39%
MDXGMimedx Group Inc20.55-2501.78%
XOMAXOMA Royalty Corp22.87-2773.22%
ARGXArgen X SE24.30-2939.56%
CTMXCytomX Therapeutics Inc24.82-3000.69%
XOMAOXOMA Royalty Corp25.34-3061.89%
HALOHalozyme Therapeutics Inc25.62-3094.48%
XOMAPXOMA Royalty Corp25.67-3099.91%
VRTXVertex Pharmaceuticals Inc27.99-3371.57%
RPRXRoyalty Pharma plc - Class A28.69-3452.53%
SLNOSoleno Therapeutics Inc29.02-3490.84%
ASNDAscendis Pharma A/S30.09-3615.91%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4530.54%
APLSApellis Pharmaceuticals Inc39.02-4660.17%
BMRNBiomarin Pharmaceutical Inc42.21-5033.04%
KRYSKrystal Biotech Inc45.34-5399.01%
ONCBeiGene Ltd69.54-8226.76%
PHARPharming Group N.V.75.03-8867.78%
TECHBio-Techne Corp101.96-12015.25%
VCELVericel Corp109.92-12945.83%
ALNYAlnylam Pharmaceuticals Inc117.96-13885.85%
GMABGenmab140.29-16494.92%
TLXTelix Pharmaceuticals Ltd162.15-19049.80%
CORTCorcept Therapeutics Inc212.86-24975.35%